How this ETF's holdings score on the six lenses, weighted by holding weight. A transparency roll-up of the stock atom — descriptive, not a forecast of outperformance.
Glass box
Click a lens to expand its holdings, ranked by contribution (weight × decile); each name links to its own evidence. Descriptive, not a forecast.
No NSE price series mapped for this ETF — lens roll-up only.
| Symbol | Sector | Weight | Tch | Fnd | Cat | Flw | Val | Lead | RS 3M |
|---|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | Pharma | 10.06% | 7 | 8 | 7 | 8 | 5 | — | +1.5% |
| DIVISLAB | Pharma | 7.36% | 9 | 8 | 1 | 4 | 1 | — | +38.4% |
| APOLLOHOSP | Healthcare | 6.63% | 9 | 5 | 5 | 2 | 2 | — | +0.4% |
| CIPLA | Pharma | 5.96% | 4 | 3 | 6 | 4 | 7 | — | -3.9% |
| MAXHEALTH | Healthcare | 5.88% | 1 | 9 | 6 | 5 | 6 | — | -6.0% |
| TORNTPHARM | Pharma | 5.40% | 7 | 8 | 5 | 4 | 1 | — | +7.0% |
| LAURUSLABS | Pharma | 5.08% | 9 | 9 | 3 | 3 | 1 | — | +29.2% |
| DRREDDY | Pharma | 5.03% | 2 | 2 | 6 | 10 | 9 | — | -14.7% |
| LUPIN | Pharma | 4.22% | 3 | 10 | 10 | 7 | 9 | — | -11.1% |
| FORTIS | Healthcare | 3.54% | 4 | 8 | 5 | 5 | 6 | — | -12.4% |
| AUROPHARMA | Pharma | 3.14% | 8 | 3 | 10 | 6 | 7 | — | +9.9% |
| GLENMARK | Pharma | 2.42% | 10 | 9 | 9 | 4 | 3 | — | +8.2% |
| ALKEM | Pharma | 2.42% | 3 | 8 | 7 | 6 | 8 | — | -6.6% |
| BIOCON | Pharma | 2.18% | 4 | 1 | 10 | 2 | 7 | — | -8.8% |
| ZYDUSLIFE | Pharma | 2.03% | 9 | 10 | 10 | 2 | 8 | — | +1.9% |
| MANKIND | Pharma | 2.01% | 4 | 8 | 9 | 3 | 5 | — | -6.1% |
| IPCALAB | Pharma | 1.75% | 9 | 5 | 1 | 3 | 4 | — | +14.3% |
| KIMS | Healthcare | 1.50% | 4 | 3 | 6 | 10 | 2 | — | -9.0% |
| ASTERDM | Healthcare | 1.50% | 6 | 2 | 9 | 4 | 2 | — | -0.6% |
| GLAND | Pharma | 1.43% | 10 | 7 | 5 | 4 | 4 | Leader | +27.9% |
| SAILIFE | Healthcare | 1.30% | 9 | 10 | 5 | 9 | 1 | Leader | +27.8% |
| NEULANDLAB | Healthcare | 1.17% | 8 | 10 | 7 | 4 | 1 | — | +30.4% |
| WOCKPHARMA | Pharma | 1.16% | 10 | 3 | 3 | 8 | 1 | Leader | +12.2% |
| ACUTAAS | Chemicals | 1.16% | 5 | 10 | 3 | 8 | 2 | — | -8.5% |
| LALPATHLAB | Healthcare | 1.07% | 7 | 8 | 7 | 5 | 3 | — | +18.6% |
| AJANTPHARM | Pharma | 1.05% | 8 | 10 | 1 | 3 | 3 | — | +13.9% |
| ABBOTINDIA | Pharma | 1.03% | 3 | 9 | — | 6 | 8 | — | -3.8% |
| NH | Healthcare | 1.01% | 5 | 8 | 7 | 10 | 4 | — | -4.9% |
| ONESOURCE | Healthcare | 0.92% | 3 | 1 | 6 | 7 | 8 | — | -15.1% |
| PPLPHARMA | Pharma | 0.87% | 10 | 1 | 5 | 9 | 5 | Leader | +28.4% |
| MEDANTA | Healthcare | 0.86% | 8 | 9 | 5 | 4 | 2 | — | +13.1% |
| GRANULES | Healthcare | 0.86% | 10 | 9 | 5 | 6 | 6 | Leader | +8.7% |
| GLAXO | Healthcare | 0.79% | 8 | 7 | 2 | 8 | 4 | — | +31.0% |
| NATCOPHARM | Healthcare | 0.59% | 2 | 4 | 8 | 10 | 10 | — | -7.9% |
| RAINBOW | Healthcare | 0.55% | 10 | 7 | 4 | 3 | 4 | — | +5.0% |
| JUBLPHARMA | Pharma | 0.54% | 3 | 1 | 3 | 3 | 7 | — | -5.2% |
| SYNGENE | Healthcare | 0.53% | 1 | 2 | 6 | 7 | 7 | — | -17.8% |
| ERIS | Pharma | 0.53% | 3 | 8 | 4 | 9 | 8 | — | -7.4% |
| PFIZER | Healthcare | 0.52% | 5 | 7 | 1 | 8 | 7 | — | -2.9% |
| ANTHEM | Pharma | 0.52% | 10 | 10 | 6 | 3 | 1 | Leader | +16.3% |
| COHANCE | Healthcare | 0.50% | 4 | 5 | 6 | 3 | 5 | — | +1.5% |
| EMCURE | Pharma | 0.48% | 10 | 10 | 9 | 10 | 4 | Leader | +7.6% |
| VIJAYA | Pharma | 0.47% | 7 | 10 | 5 | 4 | 1 | — | +10.1% |
| POLYMED | Healthcare | 0.47% | 6 | 6 | 5 | 6 | 6 | — | +18.6% |
| INDGN | Healthcare | 0.38% | 7 | 8 | 7 | 6 | 6 | — | +12.6% |
| CAPLIPOINT | Pharma | 0.36% | 10 | 9 | 2 | 4 | 6 | — | +28.9% |
| CONCORDBIO | Pharma | 0.34% | 8 | 4 | 2 | 5 | 3 | — | +16.2% |
| BLUEJET | Pharma | 0.23% | 8 | 10 | 3 | 10 | 4 | — | +21.8% |
Native from atlas_foundation — the lens journal looked through de_etf_holdings; identity from Morningstar (de_mf_master). ← Back to ETFs